- Home
- QNRX vs XXII Comparison
QNRX vs XXII Comparison
Compare QNRX & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNRX
- XXII
- Stock Information
- Founded
- QNRX 2018
- XXII 1998
- Country
- QNRX United States
- XXII United States
- Employees
- QNRX N/A
- XXII N/A
- Industry
- QNRX Medical/Dental Instruments
- XXII Medicinal Chemicals and Botanical Products
- Sector
- QNRX Health Care
- XXII Health Care
- Exchange
- QNRX Nasdaq
- XXII Nasdaq
- Market Cap
- QNRX 2.5M
- XXII 2.1M
- IPO Year
- QNRX N/A
- XXII N/A
- Fundamental
- Price
- QNRX $7.12
- XXII $0.80
- Analyst Decision
- QNRX
- XXII
- Analyst Count
- QNRX 0
- XXII 0
- Target Price
- QNRX N/A
- XXII N/A
- AVG Volume (30 Days)
- QNRX 355.0K
- XXII 1.6M
- Earning Date
- QNRX 05-08-2025
- XXII 05-14-2025
- Dividend Yield
- QNRX N/A
- XXII N/A
- EPS Growth
- QNRX N/A
- XXII N/A
- EPS
- QNRX N/A
- XXII N/A
- Revenue
- QNRX N/A
- XXII $24,382,000.00
- Revenue This Year
- QNRX N/A
- XXII $19.23
- Revenue Next Year
- QNRX N/A
- XXII $81.05
- P/E Ratio
- QNRX N/A
- XXII N/A
- Revenue Growth
- QNRX N/A
- XXII N/A
- 52 Week Low
- QNRX $5.01
- XXII $0.70
- 52 Week High
- QNRX $54.95
- XXII $265.95
- Technical
- Relative Strength Index (RSI)
- QNRX 46.54
- XXII 26.33
- Support Level
- QNRX $5.27
- XXII $0.70
- Resistance Level
- QNRX $7.22
- XXII $0.83
- Average True Range (ATR)
- QNRX 1.12
- XXII 0.21
- MACD
- QNRX 0.22
- XXII 0.05
- Stochastic Oscillator
- QNRX 62.79
- XXII 5.92
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.